Search
for
Sort by
Research 361–390 of 1000+
- Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib
- Treatments for alopecia areata: a network meta-analysis
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- An Open-Label Comparative Study on the Effects of Platelet-Rich Plasma Therapy with Hydroquinone 4% Versus Hydroquinone 4% Alone in Melasma
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Redefining hormone resistance in prostate cancer
- Direct Vasodilators and Sympatholytic Agents
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- The role of B cell-activating factor system in autoimmune diseases: mechanisms, disease implications, and therapeutic advances
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Hidradenitis Suppurativa/Acne Inversa/Dissecting Terminal Hair Folliculitis
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Effectiveness of fractional erbium–YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial
- Hair Loss in Children
- Endocrine disorders and hormonal therapy for adolescent acne
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Efficacy and safety of tofacitinib in pediatric patients with alopecia areata: A prospective cohort study
- Novel drugs of United States Food and Drug Administration approved in 2024
- 0054 Treg-targeted therapies restrain disease in a murine model of alopecia areata
- Poster Presentations
- Efficacy and Safety of Oral Betamethasone Mini-Pulses in Moderate to Severe Alopecia Areata
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis.